Skip to content
10-Q/A

Quarterly Report

Medicale Corp. MCLE

0001683168-25-001130

← back to feed
Filed
Feb 20, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Feb 19, 2025 5.92M sh
Shares Diluted Q1 2025 · Dec 31, 2024 5.92M sh
Shares Diluted Q1 2025 · Dec 31, 2023 5.92M sh
Operating Cash Flow Q1 2025 · Dec 31, 2024 −$10K
Operating Cash Flow restated Q1 2025 · Dec 31, 2023 −$27.71K
Stockholders Equity restated Q1 2025 · Dec 31, 2024 −$115.61K
Stockholders Equity Q1 2025 · Sep 30, 2024 −$98.93K
Stockholders Equity Q1 2025 · Dec 31, 2023 −$60.03K
Stockholders Equity Q1 2025 · Sep 30, 2023 −$40.72K
Current Liabilities restated Q1 2025 · Dec 31, 2024 $22.19K
Current Liabilities Q1 2025 · Sep 30, 2024 $15.51K
Total Liabilities restated Q1 2025 · Dec 31, 2024 $115.77K
Total Liabilities Q1 2025 · Sep 30, 2024 $99.09K
Current Assets Q1 2025 · Dec 31, 2024 $159
Current Assets Q1 2025 · Sep 30, 2024 $159
Total Assets Q1 2025 · Dec 31, 2024 $159
Total Assets Q1 2025 · Sep 30, 2024 $159
Eps Diluted Q1 2025 · Dec 31, 2024 $0.00
Eps Diluted Q1 2025 · Dec 31, 2023 $0.00
Eps Basic Q1 2025 · Dec 31, 2024 $0.00
Eps Basic Q1 2025 · Dec 31, 2023 $0.00
Sga Expense restated Q1 2025 · Dec 31, 2024 $15K
Sga Expense Q1 2025 · Dec 31, 2023 $19.31K
Net Income restated Q1 2025 · Dec 31, 2024 −$16.68K
Net Income Q1 2025 · Dec 31, 2023 −$19.31K
Operating Income restated Q1 2025 · Dec 31, 2024 −$15K
Operating Income Q1 2025 · Dec 31, 2023 −$19.31K